1. Home
  2. EXAI

EXAI

Exscientia Plc

Logo Exscientia Plc

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-17-2024 10:43am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe, and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.

Founded: 2012 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 587.1M IPO Year: 2021
Target Price: $9.75 AVG Volume (30 days): 743.3K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.47 EPS Growth: N/A
52 Week Low/High: $4.17 - $9.12 Next Earning Date: 05-22-2024
Revenue: $25,416,456 Revenue Growth: -26.24%
Revenue Growth (this year): 196.9% Revenue Growth (next year): -47.48%

Share on Social Networks: